ASX:IVX Invion (IVX) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IVX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume471,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invion alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Invion Stock (ASX:IVX)Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> IVX Stock News HeadlinesApril 21, 2024 | msn.comUkrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'April 16, 2024 | morningstar.comInVision Software AG IVXApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 11, 2024 | theguardian.comFirst Thing: Date set for Israel’s invasion of Rafah, Netanyahu saysApril 11, 2024 | mirror.co.ukIsrael has date picked out for 'eliminating terrorist battalions' in Rafah ground invasionApril 9, 2024 | usatoday.comSuspect charged with murder, home invasion in deadly Illinois stabbing and beating rampageMarch 17, 2024 | theglobeandmail.comStocks in August are DROPPING – Here’s WhyMarch 15, 2024 | theglobeandmail.comGas Prices About to Skyrocket, Gas Economics 101April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 6, 2024 | bbc.co.ukWatch: Tumbleweed invasion engulfs US streetsFebruary 26, 2024 | msn.comDoctor Who 1960s movies get price cutDecember 14, 2023 | bbc.comUkraine invasion: False claims the war is a hoax go viralNovember 29, 2023 | businessinsider.comRussia was taken by surprise when it lost 76 passenger planes due to Ukraine invasion sanctions, minister saysNovember 29, 2023 | businessinsider.comRussia offered to end its invasion of Ukraine if it dumped plans to join NATO, but Kyiv feared a double cross, says negotiatorNovember 21, 2023 | nypost.comPhilly business owner and his family tied up in home invasion witnessed by 4-year-old daughter: videoNovember 19, 2023 | theguardian.comRussia-Ukraine war at a glance: what we know on day 602 of the invasionOctober 27, 2023 | mirror.co.ukPalestinians trying to flee Israel Gaza invasion scream 'we didn't kill anyone'October 27, 2023 | theglobeandmail.comMeta Sparks a Sharp Sell-off in Tech StocksOctober 24, 2023 | usatoday.com'Preparing to die': Palestinians flee as Gaza braces for Israeli ground invasionOctober 23, 2023 | theglobeandmail.comMarkets Today: Global Stocks Slide as Bond Yields ClimbOctober 18, 2023 | mirror.co.ukBritain faces invasion of 'super' bedbugs 'resistant to insecticides', expert warnsOctober 13, 2023 | theglobeandmail.comStocks End Mostly Lower on Geopolitical Risks in the Middle EastOctober 12, 2023 | theglobeandmail.comMiddle East War: 3 Top-Rated Defense Stocks for Your PortfolioOctober 11, 2023 | theguardian.comRussia-Ukraine war at a glance: what we know on day 591 of the invasionSeptember 24, 2023 | msn.comASX Health Stocks: Starpharma full steam ahead on VIRALEZE study, Dimerix to use QYTOVRA as brand nameAugust 23, 2023 | cbsnews.comMan charged in Indiana County home invasionJuly 20, 2023 | theguardian.comSecret Invasion recap episode one – it’s true, the world has been invaded by reptilians disguised as humans!See More Headlines Receive IVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:IVX CUSIPN/A CIKN/A Webwww.inviongroup.com Phone61 3 9081 6005FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,500,000.00 Net Margins-34.15% Pretax MarginN/A Return on Equity-8.12% Return on Assets-5.16% Debt Debt-to-Equity RatioN/A Current Ratio9.19 Quick Ratio18.63 Sales & Book Value Annual Sales$4.39 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow15.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,420,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.20 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Thian ChewExecutive Chairman & CEOMs. Melanie Jaye Leydin B.Bus (Age 51)C.A., Chief Financial Officer Dr. Dean NaylorHead of Intellectual Property DevelopmentMs. Claire Newstead-Sinclair C.A.Company SecretaryKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersRobert (Rob) MerrielSold 2,900,000 sharesTotal: $14,500.00 ($0.01/share)Robert (Rob) MerrielBought 1,540,125 shares on 5/1/2023Total: $10,780.88 ($0.01/share) IVX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Invion own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invion investors own include Denbury Resources (DNR), Walt Disney (DIS), Carlisle Companies (CSL), Cyclone Metals Limited (CFE.AX) (CFE), Camtek (CAMT), Boston Properties (BXP), BioSpecifics Technologies (BSTC), BJ's Restaurants (BJRI), Banco Bradesco (BBD) and Aggreko (AGK). This page (ASX:IVX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invion Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
